RU2009103367A - METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE - Google Patents
METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE Download PDFInfo
- Publication number
- RU2009103367A RU2009103367A RU2009103367/15A RU2009103367A RU2009103367A RU 2009103367 A RU2009103367 A RU 2009103367A RU 2009103367/15 A RU2009103367/15 A RU 2009103367/15A RU 2009103367 A RU2009103367 A RU 2009103367A RU 2009103367 A RU2009103367 A RU 2009103367A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- heart disease
- blood serum
- patient
- followed
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Способ оценки эффективности лечения ишемической болезни сердца путем исследования сыворотки крови до и после лечения, отличающийся тем, что определяют уровень ЛП(а) путем дополнительной обработки 0,3 мл сыворотки крови 0,1 мл 0,1% раствора тритона Х-100 и инкубируют 15 мин при 20°С, последующей инкубацией сыворотки крови больного с раствором Судана Б в течение 1 ч в темном термостате при 40°С, и затем внесения пробы больного в лунку в геле агарозы с площадью 4×20 мм с последующей фиксацией электрофореграмм, их высушиванием и денситометрией и при снижении уровня ЛП(а) на 40% и более по сравнению с исходным уровнем оценивают лечение ишемической болезни сердца как эффективное. A method for evaluating the effectiveness of treatment of coronary heart disease by examining blood serum before and after treatment, characterized in that the level of LP (a) is determined by additional processing of 0.3 ml of blood serum with 0.1 ml of 0.1% X-100 triton solution and incubated 15 min at 20 ° C, followed by incubation of the patient’s blood serum with Sudan B solution for 1 h in a dark thermostat at 40 ° C, and then the patient’s samples were added to the hole in an agarose gel with an area of 4 × 20 mm, followed by fixation of electrophoregrams; drying and densitometry and at lower SRI level PL (a) 40% or more compared with baseline estimate treatment of ischemic heart disease as effective.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009103367/15A RU2400759C1 (en) | 2009-02-02 | 2009-02-02 | Method of estimating efficiency of coronary heart disease treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009103367/15A RU2400759C1 (en) | 2009-02-02 | 2009-02-02 | Method of estimating efficiency of coronary heart disease treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2009103367A true RU2009103367A (en) | 2010-08-10 |
RU2400759C1 RU2400759C1 (en) | 2010-09-27 |
Family
ID=42698655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009103367/15A RU2400759C1 (en) | 2009-02-02 | 2009-02-02 | Method of estimating efficiency of coronary heart disease treatment |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2400759C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110791122A (en) * | 2019-11-28 | 2020-02-14 | 迈克生物股份有限公司 | Sudan black B staining kit |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2476883C1 (en) * | 2011-07-26 | 2013-02-27 | Государственное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" | Method for estimating clinical effectiveness of ischemic heart disease |
RU2462718C1 (en) * | 2011-08-09 | 2012-09-27 | Государственное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" | Method for evaluating clinical effectiveness in lipidemia |
-
2009
- 2009-02-02 RU RU2009103367/15A patent/RU2400759C1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110791122A (en) * | 2019-11-28 | 2020-02-14 | 迈克生物股份有限公司 | Sudan black B staining kit |
Also Published As
Publication number | Publication date |
---|---|
RU2400759C1 (en) | 2010-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Trefz et al. | The prevalence and clinical relevance of hyperkalaemia in calves with neonatal diarrhoea | |
EA201300244A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | |
EA201100440A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR CORRECTION OF URIC ACID LEVEL | |
BR112013031591A2 (en) | circulation biomarkers for cancer | |
BR112014002975A2 (en) | biomarker compositions and methods | |
EA201000630A1 (en) | APPLICATION OF BENZO-CONDENSED HETERO-CYCLIC SULFAMIDE DERIVATIVES TO REDUCE LIPPLE LEVELS IN THE BLOOD | |
CY1113403T1 (en) | NEW INDUSTRIAL INDICATOR FOR MONITORING THE EVOLUTION OF DISEASES AND ASSESSING THE EFFECTIVENESS OF THERAPIES | |
BR112015007144A2 (en) | use of masitinib for cancer treatment in patient subpopulations identified using predictive factors | |
BR112017025459A2 (en) | composition, method for treating sickle cell disease, kit, method for detection of sodium pentosan polysulfate (pps) | |
EA201270316A1 (en) | GALEKTIN-3 AND HEART RESINCHRONIZING THERAPY | |
UA114304C2 (en) | METHOD OF REDUCING SERUM UREA ACID LEVELS IN HUMANS | |
Caster et al. | Circulating microRNA‑122,‑21 and‑223 as potential markers of liver injury following warm ischaemia and reperfusion in rats | |
EA201590686A1 (en) | TEST ON MITOCHONDRIAL TOXICITY | |
RU2009103367A (en) | METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE | |
RU2009145864A (en) | METHOD FOR Predicting Heart Dysadaptation in Children After Cardiac Surgery Correction of Congenital Heart Disease | |
Dekleva et al. | Cardiopulmonary exercise testing and its relation to oxidative stress in patients with hypertension | |
RU2011131413A (en) | METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE | |
RU2009103464A (en) | METHOD FOR DETERMINING BLOOD LIPOPROTEIN FRACTIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | |
WO2009143478A3 (en) | Efficient wellbeing assessment and improved treatment protocol | |
DE602004027613D1 (en) | THERAPEUTIC, PROPHYLACTIC AND DIAGNOSTIC ACTIVE SUBSTANCES | |
RU2006142168A (en) | METHOD FOR ESTIMATING EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH HYPERTENSIVE DISEASE | |
RU2008141837A (en) | METHOD FOR PREDICTING THE COURSE OF DISEASE IN UTERINE BODY CANCER PATIENTS | |
RU2012147102A (en) | METHOD FOR PREDICTING THE COURSE OF ISCHEMIC HEART DISEASE | |
RU2011132235A (en) | METHOD FOR FORECASTING THE COURSE OF ISCHEMIC HEART DISEASE | |
Schwab et al. | Blood pressure response to a standard stimulus in the white and Negro races |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110203 |